Guardant Health, Inc. Cash Flow Statement
GH / Health Care|10 years of annual SEC 10-K data (FY2016-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 10 fiscal years. All figures from audited SEC 10-K filings.
Guardant Health, Inc. used $185M in operating cash flow and negative free cash flow of $233M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$416.3M | -$436.4M | -$479.4M | -$654.6M | -$384.8M | -$246.3M | -$75.7M | -$84.3M | -$83.2M | -$46.1M |
| Depreciation & Amortization | $39.7M | $42.4M | $42.9M | $36.0M | $22.3M | $16.1M | $11.4M | $7.1M | $5.2M | $3.7M |
| Operating Cash Flow | -$184.8M | -$239.9M | -$325.0M | -$309.5M | -$209.0M | -$103.9M | -$47.1M | -$72.2M | -$72.2M | -$36.7M |
| Capital Expenditures | $48.3M | $35.1M | $20.5M | $77.5M | $75.0M | $36.2M | $18.7M | $20.2M | $6.7M | $1.8M |
| Free Cash Flow | -$233.1M | -$274.9M | -$345.5M | -$386.9M | -$284.1M | -$140.1M | -$65.9M | -$92.4M | -$78.9M | -$38.5M |
| Share Buybacks | $45.0M | $0 | $0 | - | - | $0 | $0 | $172.0K | $7.2M | $100.0K |
| FCF Margin | -23.7% | -37.2% | -61.3% | -86.1% | -76.0% | -48.9% | -30.7% | - | - | - |